Just bought more $SLMT. 😎

#wednesdaymotivation $ZSPC Let’s go!

I think $MSTY will start climbing in 2026. Meanwhile, thanks for the weekly #dividends! #dividendstocksrock

No. 6 #Wrapped2025: Precision Measurement. 📏 Just launched in November! This new app ensures students master the fundamental tools of manufacturing—calipers and micrometers—before touching materials.

I DON'T UNDERSTAND WHY PEOPLE DON'T USE GROK FOR STOCKS. Most traders are looking at charts from 3 months ago. Grok analyzes real-time sentiment on X to predict tomorrow. Here are 8 prompts to find the next 10x stock:

Here's a short list of Dividend stocks and ETFs I intend to buy consistently over the next year 2026🤑 $VIG $FDVV $DGRW $KQQQ $DIVO $QDVO $GPIQ $QQQI $SPYI $BTCI $OMAH $SIOO And many more! Which names are you planning on buying this year?

Is $PRPH going to make a move in January 2026? “ProPhase Labs Signs Non-Binding LOI for Proposed Reverse Merger with Advanced Biological Laboratories.”

Hey Grok who’s posting purchases of $ASST and how many shares have been purchased in the past 2 weeks?

“Can-Fite Granted Brazilian Patent for Treatment of Sexual Dysfunction” $CANF That should send it by February!

I got a good feeling about the week ahead $BTC $SHIB $BONK

Hey Grok, what are people saying about $ASST? Are they buying?

THIS is why Airlines hate GROK⚠️ My flight was $1,260, I paid $118. No points. No shady third-party apps. Copy these 7 prompts and see the magic:

Stock Kid Abdul Șhakoor Based on the thread's engagement metrics (likes and views), the Undervalued Stock Screener (prompt 1) seems most popular so far. However, with the thread being new, actual usage data is limited—check back in a few days!

I’m guessing $ASST will get to $15 by Valentin’s ❤️ Day!

Hey Grok please give me the Top 5 dividend paying ETFs (which pay their dividends quarterly or even weekly), that trade under $50, and all contain all 7 of the Magnificent 7 stocks $AAPL $MSFT $AMZN $GOOGL $META $NVDA and $TSLA .

Brand new year and new buying has started. Come on $IBRX , give us some great news!

$NVVE low float, big runner possible

$IBRX Let’s go! “Saudi FDA Grants Accelerated Approval to ImmunityBio’s ANKTIVA® In Combination with Checkpoint Inhibitors for Metastatic Non-Small Cell Lung Cancer”

$IBRX is looking good. Still holding for more upside.